Global Coagulation Factor IX Market Growth 2024-2030

Publication ID:

LPI01250367

Publication Date:

February 7, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Coagulation Factor IX market size was valued at US$ 354.1 million in 2023. With growing demand in downstream market, the Coagulation Factor IX is forecast to a readjusted size of US$ 533.1 million by 2030 with a CAGR of 6.0% during review period.
The research report highlights the growth potential of the global Coagulation Factor IX market. Coagulation Factor IX are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Coagulation Factor IX. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Coagulation Factor IX market.
Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Coagulation Factor IX market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Coagulation Factor IX market. It may include historical data, market segmentation by Type (e.g., Coagulation Factor IX (Plasma Derived), Coagulation Factor IX (Recombinant)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Coagulation Factor IX market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Coagulation Factor IX market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Coagulation Factor IX industry. This include advancements in Coagulation Factor IX technology, Coagulation Factor IX new entrants, Coagulation Factor IX new investment, and other innovations that are shaping the future of Coagulation Factor IX.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Coagulation Factor IX market. It includes factors influencing customer ' purchasing decisions, preferences for Coagulation Factor IX product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Coagulation Factor IX market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Coagulation Factor IX market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Coagulation Factor IX market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Coagulation Factor IX industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Coagulation Factor IX market.
Market Segmentation:
Coagulation Factor IX market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Coagulation Factor IX (Plasma Derived)
Coagulation Factor IX (Recombinant)
Segmentation by application
Adult
Kids
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
CSL Behring
Grifols
Novo Nordisk
Bioverativ
Sanquin
Takeda
Baxter
Aptevo
Key Questions Addressed in this Report
What is the 10-year outlook for the global Coagulation Factor IX market?
What factors are driving Coagulation Factor IX market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Coagulation Factor IX market opportunities vary by end market size?
How does Coagulation Factor IX break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Coagulation Factor IX Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Coagulation Factor IX by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Coagulation Factor IX by Country/Region, 2019, 2023 & 2030
2.2 Coagulation Factor IX Segment by Type
2.2.1 Coagulation Factor IX (Plasma Derived)
2.2.2 Coagulation Factor IX (Recombinant)
2.3 Coagulation Factor IX Sales by Type
2.3.1 Global Coagulation Factor IX Sales Market Share by Type (2019-2024)
2.3.2 Global Coagulation Factor IX Revenue and Market Share by Type (2019-2024)
2.3.3 Global Coagulation Factor IX Sale Price by Type (2019-2024)
2.4 Coagulation Factor IX Segment by Application
2.4.1 Adult
2.4.2 Kids
2.5 Coagulation Factor IX Sales by Application
2.5.1 Global Coagulation Factor IX Sale Market Share by Application (2019-2024)
2.5.2 Global Coagulation Factor IX Revenue and Market Share by Application (2019-2024)
2.5.3 Global Coagulation Factor IX Sale Price by Application (2019-2024)
3 Global Coagulation Factor IX by Company
3.1 Global Coagulation Factor IX Breakdown Data by Company
3.1.1 Global Coagulation Factor IX Annual Sales by Company (2019-2024)
3.1.2 Global Coagulation Factor IX Sales Market Share by Company (2019-2024)
3.2 Global Coagulation Factor IX Annual Revenue by Company (2019-2024)
3.2.1 Global Coagulation Factor IX Revenue by Company (2019-2024)
3.2.2 Global Coagulation Factor IX Revenue Market Share by Company (2019-2024)
3.3 Global Coagulation Factor IX Sale Price by Company
3.4 Key Manufacturers Coagulation Factor IX Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Coagulation Factor IX Product Location Distribution
3.4.2 Players Coagulation Factor IX Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Coagulation Factor IX by Geographic Region
4.1 World Historic Coagulation Factor IX Market Size by Geographic Region (2019-2024)
4.1.1 Global Coagulation Factor IX Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Coagulation Factor IX Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Coagulation Factor IX Market Size by Country/Region (2019-2024)
4.2.1 Global Coagulation Factor IX Annual Sales by Country/Region (2019-2024)
4.2.2 Global Coagulation Factor IX Annual Revenue by Country/Region (2019-2024)
4.3 Americas Coagulation Factor IX Sales Growth
4.4 APAC Coagulation Factor IX Sales Growth
4.5 Europe Coagulation Factor IX Sales Growth
4.6 Middle East & Africa Coagulation Factor IX Sales Growth
5 Americas
5.1 Americas Coagulation Factor IX Sales by Country
5.1.1 Americas Coagulation Factor IX Sales by Country (2019-2024)
5.1.2 Americas Coagulation Factor IX Revenue by Country (2019-2024)
5.2 Americas Coagulation Factor IX Sales by Type
5.3 Americas Coagulation Factor IX Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Coagulation Factor IX Sales by Region
6.1.1 APAC Coagulation Factor IX Sales by Region (2019-2024)
6.1.2 APAC Coagulation Factor IX Revenue by Region (2019-2024)
6.2 APAC Coagulation Factor IX Sales by Type
6.3 APAC Coagulation Factor IX Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Coagulation Factor IX by Country
7.1.1 Europe Coagulation Factor IX Sales by Country (2019-2024)
7.1.2 Europe Coagulation Factor IX Revenue by Country (2019-2024)
7.2 Europe Coagulation Factor IX Sales by Type
7.3 Europe Coagulation Factor IX Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Coagulation Factor IX by Country
8.1.1 Middle East & Africa Coagulation Factor IX Sales by Country (2019-2024)
8.1.2 Middle East & Africa Coagulation Factor IX Revenue by Country (2019-2024)
8.2 Middle East & Africa Coagulation Factor IX Sales by Type
8.3 Middle East & Africa Coagulation Factor IX Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Coagulation Factor IX
10.3 Manufacturing Process Analysis of Coagulation Factor IX
10.4 Industry Chain Structure of Coagulation Factor IX
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Coagulation Factor IX Distributors
11.3 Coagulation Factor IX Customer
12 World Forecast Review for Coagulation Factor IX by Geographic Region
12.1 Global Coagulation Factor IX Market Size Forecast by Region
12.1.1 Global Coagulation Factor IX Forecast by Region (2025-2030)
12.1.2 Global Coagulation Factor IX Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Coagulation Factor IX Forecast by Type
12.7 Global Coagulation Factor IX Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Coagulation Factor IX Product Portfolios and Specifications
13.1.3 Pfizer Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 CSL Behring
13.2.1 CSL Behring Company Information
13.2.2 CSL Behring Coagulation Factor IX Product Portfolios and Specifications
13.2.3 CSL Behring Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 CSL Behring Main Business Overview
13.2.5 CSL Behring Latest Developments
13.3 Grifols
13.3.1 Grifols Company Information
13.3.2 Grifols Coagulation Factor IX Product Portfolios and Specifications
13.3.3 Grifols Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Grifols Main Business Overview
13.3.5 Grifols Latest Developments
13.4 Novo Nordisk
13.4.1 Novo Nordisk Company Information
13.4.2 Novo Nordisk Coagulation Factor IX Product Portfolios and Specifications
13.4.3 Novo Nordisk Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Novo Nordisk Main Business Overview
13.4.5 Novo Nordisk Latest Developments
13.5 Bioverativ
13.5.1 Bioverativ Company Information
13.5.2 Bioverativ Coagulation Factor IX Product Portfolios and Specifications
13.5.3 Bioverativ Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Bioverativ Main Business Overview
13.5.5 Bioverativ Latest Developments
13.6 Sanquin
13.6.1 Sanquin Company Information
13.6.2 Sanquin Coagulation Factor IX Product Portfolios and Specifications
13.6.3 Sanquin Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Sanquin Main Business Overview
13.6.5 Sanquin Latest Developments
13.7 Takeda
13.7.1 Takeda Company Information
13.7.2 Takeda Coagulation Factor IX Product Portfolios and Specifications
13.7.3 Takeda Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Takeda Main Business Overview
13.7.5 Takeda Latest Developments
13.8 Baxter
13.8.1 Baxter Company Information
13.8.2 Baxter Coagulation Factor IX Product Portfolios and Specifications
13.8.3 Baxter Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Baxter Main Business Overview
13.8.5 Baxter Latest Developments
13.9 Aptevo
13.9.1 Aptevo Company Information
13.9.2 Aptevo Coagulation Factor IX Product Portfolios and Specifications
13.9.3 Aptevo Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Aptevo Main Business Overview
13.9.5 Aptevo Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂